Soligenix
SNGX
#10565
Rank
ยฃ5.06 M
Marketcap
ยฃ0.34
Share price
7.17%
Change (1 day)
-75.20%
Change (1 year)

EPS for Soligenix (SNGX)

EPS in 2025 (TTM): -ยฃ2.43

According to Soligenix's latest financial reports the company's current EPS (TTM) is -ยฃ2.42. In 2024 the company made an earnings per share (EPS) of -ยฃ3.72 an increase over its 2023 EPS that were of -ยฃ9.46.

EPS history for Soligenix from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-ยฃ2.43-34.63%
2024-ยฃ3.72-60.66%
2023-ยฃ9.46-83.55%
2022-ยฃ57.4913.95%
2021-ยฃ50.45-56.03%
2020-ยฃ114.7533.33%
2019-ยฃ86.06-29.41%
2018-ยฃ121.92-41.38%
2017-ยฃ207.9824.73%
2016-ยฃ166.75-69%
2015-ยฃ537.89-6.25%
2014-ยฃ573.75-50.77%
2013-ยฃ1,16575.68%
2012-ยฃ663.4068.18%
2011-ยฃ394.45-69.86%
2010-ยฃ1,309-8.75%
2009-ยฃ1,43433.33%
2008-ยฃ1,076-57.14%
2007-ยฃ2,510-46.15%
2006-ยฃ4,66244.44%
2005-ยฃ3,227-40.7%
2004-ยฃ5,443-15.62%
2003-ยฃ6,451-25.52%
2002-ยฃ8,661-80.94%
2001-ยฃ45,438160.89%
2000-ยฃ17,416-40.57%
1999-ยฃ29,304-63.84%
1998-ยฃ81,042601.73%
1997-ยฃ11,549101.7%
1996-ยฃ5,726

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
ยฃ6.53-369.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
ยฃ0.98-140.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
ยฃ1.91-179.00%๐Ÿ‡ซ๐Ÿ‡ท France
Onconova Therapeutics
ONTX
-ยฃ0.71-70.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-ยฃ1.52-37.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
ยฃ1.02-142.28%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Emergent BioSolutions
EBS
ยฃ1.05-143.52%๐Ÿ‡บ๐Ÿ‡ธ USA